On Thursday, Procter & Gamble Co (NYSE:PG)’s shares declined -1.79% to $80.95.
Procter & Gamble Co (PG) stated third quarter fiscal year 2015 core earnings per share of $0.92. On a currency-neutral basis, core earnings per share raised ten percent for the quarter. Diluted net earnings, which comprise all restructuring charges and impacts from suspended operations, were $0.75 per share. Net sales were $18.1 billion, a decrease of eight percent as compared to the preceding year period, counting a negative eight percentage point impact from foreign exchange and a negative one percentage point impact from minor brand divestitures. Organic sales grew one percent.
The Procter & Gamble Company, together with its auxiliaries, manufactures and sells branded consumer packaged goods. The company operates through five segments: Beauty; Grooming; Health Care; Fabric Care and Home Care; and Baby, Feminine and Family Care.
Lifelock Inc (NYSE:LOCK)’s shares dropped -2.57% to $14.81.
Lifelock Inc (LOCK) declared that Peter Levinson has joined the company as senior vice president of product and technology.
LifeLock President Hilary Schneider stated that they’re delighted to have Peter join LifeLock. They brings visionary leadership and broad experience, particularly in the mobile space, to their product team.
LifeLock, Inc. provides identity theft protection services for consumers; and consumer risk administration services for enterprises in the United States. It protects consumer subscribers through monitoring identity-related events, such as new account openings and credit-related applications; and enterprise customers through delivering on-demand identity risk, identity authentication, and credit information about consumers.
At the end of Thursday’s trade, Mead Johnson Nutrition CO (NYSE:MJN)‘s shares dipped -2.54% to $96.41.
Mead Johnson Nutrition CO (MJN) declared its financial results for the quarter ended March 31, 2015.
Constant dollar sales(1) raised slightly more than 3 percent. Foreign currency translation reduced sales by 5 percent and stated sales reduced 2 percent.
Gross margin improved to 64.0 percent, due to pricing and lower dairy costs.
Non-GAAP EPS was up 7 percent to $1.09; GAAP EPS was $1.02.
Company reaffirms full year 2015 non-GAAP guidance.
Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, childrens nutrition, and other nutritional products. It offers routine infant formula products as a breast milk substitute for healthy infants for the use as the infant’s source of nutrition, in addition to a supplement to breastfeeding under the Enfamil Premium, Enfapro Premium, Enfamil A+, and Enfalac A+ names; and solutions products to address common feeding tolerance problems, counting spit-up, fussiness, gas, and lactose intolerance under the Enfamil Gentlease and Enfamil A.R names.
Arch Coal Inc (NYSE:ACI), ended its Thursday’s trading session with -2.53% loss, and closed at $0.994.
Arch Coal Inc (ACI) declared several changes to its board of directors in keeping with its planned succession process.
John W. Eaves, formerly Arch’s president and chief executive officer, has been elected chairman and CEO effective right away, succeeding Wesley M. Taylor, who will remain on the Arch board. Taylor stated that they have been planning for this transition and John’s election to chairman is the next logical step as they navigate this dynamic market environment. John has an incredible depth of industry knowledge and a keen ability to execute on their strategy and to guide the company successfully through these unprecedented challenges in coal markets.
Arch Coal, Inc. produces and sells thermal and metallurgical coal from surface and underground mines located in the United States. As of December 31, 2014, it operated or contracted out the operation of 16 mines; and owned or controlled about 5.1 billion tons of proven and probable recoverable reserves.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
